Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics
|
May 1, 2008
Approaches to handling pharmacodynamic baseline responses
Chantaratsamon Dansirikul, Hanna E Silber, Mats O Karlsson
Journal of Clinical Pharmacology
|
November 27, 2009
An integrated glucose-insulin model to describe oral glucose tolerance test data in healthy volunteers
Hanna E Silber, Nicolas Frey, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics
|
February 17, 2009
The impact of misspecification of residual error or correlation structure on the type I error rate for covariate inclusion
Hanna E Silber, Maria C Kjellsson, Mats O Karlsson
Basic & Clinical Pharmacology & Toxicology
|
January 7, 2010
An integrated model for the glucose-insulin system
Hanna E Silber, Petra M Jauslin, Nicolas Frey, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
June 26, 2009
Optimization of the intravenous glucose tolerance test in T2DM patients using optimal experimental design
Hanna E Silber, Joakim Nyberg, Andrew C Hooker, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 24, 2025
A semi-mechanistic population pharmacokinetic-pharmacodynamic model to assess downstream drug-target effects on erythropoiesis
S Viktor Rognås, Franziska Schaedeli Stark, Maddalena Marchesi, et al.
Journal of Clinical Pharmacology
|
September 4, 2007
An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations
Hanna E Silber, Petra M Jauslin, Nicolas Frey, et al.
Journal of Clinical Pharmacology
|
October 2, 2007
An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabetics
Petra M Jauslin, Hanna E Silber, Nicolas Frey, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 9, 2024
Immunogenicity dynamics and covariate effects after satralizumab administration predicted with a hidden Markov model
Rory Leisegang, Hanna E Silber Baumann, Siân Lennon-Chrimes, et al.
Pharmaceutical Research
|
October 6, 2010
Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis
Hanna E Silber, Claudia Burgener, Ingrid M Letellier, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Pharmacokinetics and Pharmacodynamics
|
May 1, 2008
Approaches to handling pharmacodynamic baseline responses
Chantaratsamon Dansirikul, Hanna E Silber, Mats O Karlsson
Journal of Clinical Pharmacology
|
November 27, 2009
An integrated glucose-insulin model to describe oral glucose tolerance test data in healthy volunteers
Hanna E Silber, Nicolas Frey, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics
|
February 17, 2009
The impact of misspecification of residual error or correlation structure on the type I error rate for covariate inclusion
Hanna E Silber, Maria C Kjellsson, Mats O Karlsson
Basic & Clinical Pharmacology & Toxicology
|
January 7, 2010
An integrated model for the glucose-insulin system
Hanna E Silber, Petra M Jauslin, Nicolas Frey, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
June 26, 2009
Optimization of the intravenous glucose tolerance test in T2DM patients using optimal experimental design
Hanna E Silber, Joakim Nyberg, Andrew C Hooker, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 24, 2025
A semi-mechanistic population pharmacokinetic-pharmacodynamic model to assess downstream drug-target effects on erythropoiesis
S Viktor Rognås, Franziska Schaedeli Stark, Maddalena Marchesi, et al.
Journal of Clinical Pharmacology
|
September 4, 2007
An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations
Hanna E Silber, Petra M Jauslin, Nicolas Frey, et al.
Journal of Clinical Pharmacology
|
October 2, 2007
An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabetics
Petra M Jauslin, Hanna E Silber, Nicolas Frey, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 9, 2024
Immunogenicity dynamics and covariate effects after satralizumab administration predicted with a hidden Markov model
Rory Leisegang, Hanna E Silber Baumann, Siân Lennon-Chrimes, et al.
Pharmaceutical Research
|
October 6, 2010
Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis
Hanna E Silber, Claudia Burgener, Ingrid M Letellier, et al.
Page
of 2